Inogen (INGN) Current Deferred Revenue (2013 - 2026)
Inogen (INGN) posted quarterly Current Deferred Revenue of $5.1 million for Q1 2026, down 20.59% year-over-year from $6.4 million in Q1 2025, and down 7.5% quarter-over-quarter from $5.5 million in Q4 2025.
Inogen (INGN) Current Deferred Revenue (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Current Deferred Revenue for 14 consecutive years, with $5.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 20.59% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $5.1 million (down 20.59% YoY), while the FY2025 annual figure was $5.5 million, down 17.3% from the prior year.
- Current Deferred Revenue eased to $5.1 million in Q1 2026 per INGN's latest filing, from $5.5 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $9.1 million in Q3 2022 and bottomed at $5.1 million in Q1 2026.
- Historically, Current Deferred Revenue has averaged $7.5 million across 5 years, with a median of $7.4 million in 2024.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue climbed 15.98% — and 2026, when it fell 20.59%.
- Inogen's Current Deferred Revenue stood at $8.9 million in 2022, then decreased by 10.14% to $8.0 million in 2023, then dropped by 16.62% to $6.7 million in 2024, then slipped by 17.3% to $5.5 million in 2025, then retreated by 7.5% to $5.1 million in 2026.
- Business Quant data shows INGN's Current Deferred Revenue at $5.1 million in Q1 2026, $5.5 million in Q4 2025, and $6.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Inogen | 151.72 Mn | 46.18 Mn | 43.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.72 Mn |
| Mar 31, 2026 | 5.09 Mn |
| Dec 31, 2025 | 5.50 Mn |
| Sep 30, 2025 | 5.97 Mn |
| Jun 30, 2025 | 6.26 Mn |
| Mar 31, 2025 | 6.41 Mn |
| Dec 31, 2024 | 6.65 Mn |
| Sep 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | 7.39 Mn |
| Mar 31, 2024 | 7.42 Mn |
| Dec 31, 2023 | 7.98 Mn |
| Sep 30, 2023 | 8.48 Mn |
| Jun 30, 2023 | 8.70 Mn |
| Mar 31, 2023 | 8.79 Mn |
| Dec 31, 2022 | 8.88 Mn |
| Sep 30, 2022 | 9.12 Mn |
| Jun 30, 2022 | 9.01 Mn |
| Mar 31, 2022 | 8.69 Mn |
| Dec 31, 2021 | 8.57 Mn |
| Sep 30, 2021 | 8.42 Mn |